Skip to main content
main-content

European Journal of Nuclear Medicine and Molecular Imaging OnlineFirst articles

07.12.2022 | Original Article

The utility of beta-hydroxybutyrate in detecting myocardial glucose uptake suppression in patients undergoing inflammatory [18F]-FDG PET studies

The diagnosis and follow-up of patients with cardiac inflammation and infections often require a multimodality approach that frequently incorporates [18F]-fluorodeoxyglucose positron emission tomography ([18F]-FDG PET) [ 1 ]. Active inflammatory …

Open Access 07.12.2022 | Original Article

The role of [99mTc]Tc-HFAPi SPECT/CT in patients with malignancies of digestive system: first clinical experience

An in-depth understanding of the tumour microenvironment has revealed a new player: cancer-associated fibroblasts (CAFs) [ 1 ]. The majority of epithelial tumours recruit fibroblasts and other non-malignant cells, stimulating them to become CAFs.

Open Access 07.12.2022 | Original Article

Application of the long axial field-of-view PET/CT with low-dose [18F]FDG in melanoma

Positron emission tomography (PET) integrated with computed tomography (CT) is a whole-body imaging technique combining functional and morphological information in one procedure. PET/CT, mainly with the radiotracer 2-deoxy-2-[fluorine-18] …

06.12.2022 | Image of the Month

Neurexin-3α-associated autoimmune encephalitis with intracranial diffuse large B lymphoma diagnosed on FDG and TSPO PET/MRI

06.12.2022 | Original Article

Different z-score cut-offs for striatal binding ratio (SBR) of DaT SPECT are needed to support the diagnosis of Parkinson’s Disease (PD) and dementia with Lewy bodies (DLB)

Dopamine transporter (DaT) imaging with Ioflupane labelled with iodine-123 using single-photon emission computed tomography (SPECT) allows to evaluate the presynaptic DaT expression in the striatum [ 1 ]. DaT SPECT is able to support the …

Über diese Zeitschrift

Highly ranked among journals in its field, the European Journal of Nuclear Medicine and Molecular Imaging provides a forum for the exchange of clinical and scientific information for the nuclear medicine community and allied professions involved in the functional, metabolic and molecular investigation of disease. The journal remains of primary interest to practitioners in the field of nuclear medicine but also reports on original work relating to physics, dosimetry, radiation biology, radiochemistry and pharmacy. Original material examines the field of molecular imaging probes, reporter gene assays, cell trafficking, targeting of endogenous gene expression and antisense methodologies.
The Journal publishes in-depth reviews of topical interest, short communications, controversies, interesting images and letters to the Editor.

This is the official journal of the European Association of Nuclear Medicine (EANM). EANM members, and also members of the Japanese, Korean and Italian nuclear medicine societies have free access to EJNMMI. As part of this reciprocal agreement, EANM members also have free access to “Annals of Nuclear Medicine”, “Nuclear Medicine and Molecular Imaging” and to “Clinical and Translational Imaging”.

Metadaten
Titel
European Journal of Nuclear Medicine and Molecular Imaging
Abdeckung
Volume 24/1997 - Volume 50/2022
Verlag
Springer Berlin Heidelberg
Elektronische ISSN
1619-7089
Print ISSN
1619-7070
Zeitschriften-ID
259
DOI
https://doi.org/10.1007/259.1619-7089